Effects of intravenous and oral verapamil upon pressor and adrenal steroidogenic responses in normal man
- PMID: 6306040
- DOI: 10.1210/jcem-57-2-339
Effects of intravenous and oral verapamil upon pressor and adrenal steroidogenic responses in normal man
Abstract
Slow channel calcium antagonists inhibit in vitro both vascular smooth muscle contraction and adrenal steroidogenesis. We assessed the effects of one of these drugs, verapamil, upon pressor responses and increments in plasma steroid concentrations to adrenal trophic factors in normal volunteers. Given acutely iv, verapamil in amounts sufficient to produce plasma concentrations of approximately 200 ng/ml significantly blunted the pressor action of angiotensin II in six normal subjects but did not alter increments in plasma aldosterone or cortisol in response to either angiotensin or ACTH compared to paired control studies. When verapamil was given orally (120 mg three times daily for 5 days), the plasma concentrations were equivalent to those after iv administration of the drug in six other volunteers, and verapamil again significantly blunted pressor responses to angiotensin II and norepinephrine. Oral verapamil also blunted the increments in plasma aldosterone to angiotensin and cortisol to ACTH, but did not alter the aldosterone response to ACTH. We conclude that verapamil given either acutely or chronically impaired the action of pressor hormones by a nonspecific action on vascular smooth muscle. When given for a sustained period of time, verapamil also impaired to a moderate degree adrenal steroidogenesis to two trophic factors, suggesting that its adrenal effect is time dependent.
Similar articles
-
Prolonged infusions of Ile5-angiotensin-II in sodium replete and deplete man: effects on aldosterone, ACTH, cortisol, blood pressure, and electrolyte balance.J Clin Endocrinol Metab. 1978 Mar;46(3):402-13. doi: 10.1210/jcem-46-3-402. J Clin Endocrinol Metab. 1978. PMID: 221518
-
Activity of (des-Aspartyl1)-angiotensin II and angiotensin II in man. Differences in blood pressure and adrenocortical response during normal and low sodium intake.J Clin Invest. 1978 Jan;61(1):20-31. doi: 10.1172/JCI108919. J Clin Invest. 1978. PMID: 338631 Free PMC article. Clinical Trial.
-
Dependence of aldosterone stimulation in adrenal glomerulosa cells on calcium uptake: effects of lanthanum nd verapamil.Endocrinology. 1980 Nov;107(5):1345-53. doi: 10.1210/endo-107-5-1345. Endocrinology. 1980. PMID: 6253264
-
Effects of digoxin on responsiveness to the pressor actions of angiotensin and norepinephrine in man.J Clin Endocrinol Metab. 1984 Jan;58(1):76-80. doi: 10.1210/jcem-58-1-76. J Clin Endocrinol Metab. 1984. PMID: 6315764
-
Effect of nifedipine on blood pressure and adrenocortical responses to trophic stimuli in humans.J Cardiovasc Pharmacol. 1982;4 Suppl 3:S330-4. J Cardiovasc Pharmacol. 1982. PMID: 6184563
Cited by
-
The Effects of Verapamil, Hydralazine, and Doxazosin on Renin, Aldosterone, and the Ratio Thereof.Cardiovasc Drugs Ther. 2023 Apr;37(2):283-289. doi: 10.1007/s10557-021-07262-3. Epub 2021 Sep 13. Cardiovasc Drugs Ther. 2023. PMID: 34515895 Free PMC article.
-
The Effect of Antihypertensive Medications on Testing for Primary Aldosteronism.Front Pharmacol. 2021 May 13;12:684111. doi: 10.3389/fphar.2021.684111. eCollection 2021. Front Pharmacol. 2021. PMID: 34054559 Free PMC article. Review.
-
ATR-101 inhibits cholesterol efflux and cortisol secretion by ATP-binding cassette transporters, causing cytotoxic cholesterol accumulation in adrenocortical carcinoma cells.Br J Pharmacol. 2017 Oct;174(19):3315-3332. doi: 10.1111/bph.13951. Epub 2017 Aug 30. Br J Pharmacol. 2017. PMID: 28710789 Free PMC article.
-
Effect of verapamil on aldosterone secretion in primary aldosteronism.J Endocrinol Invest. 1987 Oct;10(5):491-4. doi: 10.1007/BF03348177. J Endocrinol Invest. 1987. PMID: 3429788
-
Acute calcium entry blockade inhibits the blood pressure but not the hormonal responses to angiotensin II.Eur J Clin Pharmacol. 1989;36(6):567-73. doi: 10.1007/BF00637737. Eur J Clin Pharmacol. 1989. PMID: 2550243 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
